Tech Company Financing Transactions
UrgentRx Funding Round
On 6/30/2014, UrgentRx raised $17.5 million in Series C funding from private investors and William Morris Endeavor.
Transaction Overview
Company Name
Announced On
6/30/2014
Transaction Type
Venture Equity
Amount
$17,500,000
Round
Series C
Investors
Proceeds Purpose
The company will use the proceeds for sales and marketing expansion initiatives.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1610 Wynkoop St. 300
Denver, CO 80202
USA
Denver, CO 80202
USA
Phone
Website
Email Address
Overview
UrgentRx is a line of fast-acting, portable OTC medications providing right now relief for today's busy, on-the-go consumer. UrgentRx Fast Powders come in an innovative, fast-acting flavored powder format available in convenient, single-dose, credit-card-sized packets for easier portability and accessibility.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Lynne Millheiser
Founder
Jordan Eisenberg
VP - Marketing
Kimber Ward
VP - Sales
Tony West
Browse more venture capital transactions:
Prev: 6/30/2014: Vivify Health venture capital transaction
Next: 6/30/2014: Kiip venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs